Skip to main content
Top

Reviews in Endocrine and Metabolic Disorders

Issue 5/2023

Phenotyping the obesities

Content (16 Articles)

Open Access Obesity

Phenotyping the obesities: reality or utopia?

Piero Portincasa, Gema Frühbeck

Open Access Obesity

Towards an adiposity-related disease framework for the diagnosis and management of obesities

Carolina M. Perdomo, Icíar Avilés-Olmos, Dror Dicker, Gema Frühbeck

Open Access Obesity

Relevance of body composition in phenotyping the obesities

Laura Salmón-Gómez, Victoria Catalán, Gema Frühbeck, Javier Gómez-Ambrosi

Contribution of the microbiome for better phenotyping of people living with obesity

Agostino Di Ciaula, Leonilde Bonfrate, Mohamad Khalil, Gabriella Garruti, Piero Portincasa

Open Access Obesity

Applying psycho-behavioural phenotyping in obesity characterization

Lucía Camacho-Barcia, Ignacio Lucas, Romina Miranda-Olivos, Susana Jiménez-Murcia, Fernando Fernández-Aranda

Open Access Obesity

Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management

Alberto Preda, Federico Carbone, Amedeo Tirandi, Fabrizio Montecucco, Luca Liberale

Open Access Obesity

Precision nutrition for targeting pathophysiology of cardiometabolic phenotypes

Christopher E. Shannon, Méabh B. Ní Chathail, Sinéad M. Mullin, Andrew Meehan, Fiona C. McGillicuddy, Helen M. Roche

Open Access Obesity

Towards precision medicine in bariatric surgery prescription

Sofia S. Pereira, Marta Guimarães, Mariana P. Monteiro

Open Access Obesity

Precision nutrition in the context of bariatric surgery

Maite Aguas-Ayesa, Patricia Yárnoz-Esquíroz, Laura Olazarán, Javier Gómez-Ambrosi, Gema Frühbeck

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.